Form D Explorer

Form C-AR — Deverra Therapeutics, Inc.

0001665160-24-000561 · filed 2024-04-26

Offering

Target
Maximum
Security type
Price per security
Deadline
Oversubscription

Issuer

CIK
1822782
Entity
Corporation
Jurisdiction
DE
Address
2033 6th Ave Suite 600
Seattle, WA 28121
Phone

Most recent fiscal year financials

Total assets
$7,153,621
Cash
Short-term debt
$7,222,643
Long-term debt
Revenues
$1,677,259
COGS
$1,677,259
Taxes paid
Net income
$1,672,096

View original on SEC EDGAR.